Four Day Immersion Course
Contact Us to Enroll in Our Next Course
What is our Professional Site?
Signup to Receive News Alerts
Emerging Phase Cases
Select one of the briefcases from the Emerging Phase Cases below to begin.
ACTEMRA (tocilizumab) by Genentech USA, Inc. (Roche Group)
ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) by Abbott Vascular
EXACTECH Litigation (Optetrak Knee Replacement Devices)
HEARTSTART MRX ALS MONITOR (HeartStart MRx ALS Monitor) by Philips Healthcare
IMODIUM (loperamide) by Johnson & Johnson Consumer, Inc.
KAYEXALATE (sodium polystyrene sulfonate) by Concordia Pharmaceuticals
KEYTRUDA (pembrolizumab) by Merck Sharp & Dohme Corp.
LAMICTAL (lamotrigine) by GLAXOSMITHKLINE
LEMTRADA (alemtuzumab) by Genzyme Corporation
LIMBREL (flavocoxid) by Primus Pharmaceuticals, Inc.
NUPLAZID (pimavanserin) by ACADIA Pharmaceuticals, Inc.
SMITH & NEPHEW Journey BCS Knee System
TASIGNA (nilotinib hydrochloride monohydrate) by Novartis AG/Novartis Pharmaceuticals, Inc.
ULORIC (febuxostat) by Takeda Pharmaceuticals U.S.A., Inc.
VIBERZI (eluxadoline) by Allergan
Zantac MDL 2924 (Ranatidine) Products Liability Litigation - FL
ZINBRYTA (daclizumab) by Biogen